A Randomized, Multicenter, Phase 2 Trial of Camrelizumab With or Without Metastasis-directed Stereotactic Body Radiation Therapy in Recurrent or Metastatic Nasopharyngeal Carcinoma
To investigate the efficacy of metastasis-directed therapy (MDT) when added to camrelizumab (Cam) in patients with recurrent or metastatic nasopharyngeal carcinoma (R/M-NPC).
PDF的下载单位、IP信息已删除
(2025-6-4)
大力的灵雁
麻花阳
GingerF
无极微光
嘻嘻哈哈
猪猪hero
ccc2
mono
lizishu
飞快的从菡
9527
贪玩的秋柔
YifanWang
潇洒板栗
linley
嘉心糖
Singularity
nexus
披着羊皮的狼
DYYY
皖公网安备34019202002308
